Raziel Therapeutics is a clinical-stage pharmaceutical company developing RZL-012, an injectable treatment for aesthetics and a variety of fat disorders. A single treatment session, in which RZL-012 is injected into subcutaneous fat, results in significant and sustained reduction in fat volume.